COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 882: Articles 8811-8820  | Next

Relative positioning of B and T cell epitopes drives immunodominance.
Biavasco, R., De Giovanni, M.
10.1101/2022.02.17.480954 — Posted: 2022-02-18
Tensor decomposition reveals coordinated multicellular patterns of transcriptional variation that distinguish and stratify disease individuals
Mitchel, J., Gordon, M. G., Perez, R. K., Biederstedt, E., Bueno, R., Ye, C. J., Kharchenko, P.
10.1101/2022.02.16.480703 — Posted: 2022-02-18
On Correlation between Structural Properties and Viral Escape Measurements from Deep Mutational Scanning
Zhang, L., Domeniconi, G., Yang, C.-C.
10.1101/2022.02.17.480939 — Posted: 2022-02-18
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
Czarna, A., Plewka, J., Kresik, L., Matsuda, A., Karim, A., Robinson, C., O Byrne, S., Cunningham, F., Georgiou, I., Pachota, M., Popowicz, G., Wyatt, P. G., Dubin, G., Pyrc, K.
10.1101/2022.02.17.480845 — Posted: 2022-02-18
Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) is a host factor for RNA viruses including SARS-CoV-2
Devignot, S., Sha, T. W., Burkard, T. R., Schmerer, P., Hagelkruys, A., Mirazimi, A., Elling, U., Penninger, J. M., Weber, F.
10.1101/2022.02.17.480904 — Posted: 2022-02-18
Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance
Donnici, C., Ilincic, N., Cao, C., Zhang, C., Deveaux, G., Clifton, D. A., Buckeridge, D., Bobrovitz, N., Arora, R. K.
10.1101/2022.02.17.22271099 — Posted: 2022-02-18
Autoantibodies linked to autoimmune diseases associate with COVID-19 outcomes
Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Ostrinski, Y., Zyskind, I., Filgueiras, I. S., Schimke, L. F., Marques, A. H. C., Giil, L. M., Lavi, Y. B., Silverberg, J. I., Zimmerman, J., Hill, D. A., Thornton, A., Kim, M., De Vito, R., Fonseca, D. L. M., Placa, D. R., Freire, P. P., Camara, N. O. S., Calich, V. L. G., Heidecke, H., Lattin, M. T., Ochs, H. D., Riemekasten, G., Amital, H., Marques, O. C., Shoenfeld, Y.
10.1101/2022.02.17.22271057 — Posted: 2022-02-18
COVID-19-related Smell and Taste Impairment with Widespread Diffusion of SARS-CoV-2 Omicron Variant
Boscolo Rizzo, P., Tirelli, G., Meloni, P., Hopkins, C., Madeddu, G., De Vito, A., Gardenal, N., Valentinotti, R., Tofanelli, M., Borsetto, D., Lechien, J. R., Polesel, J., De Riu, G., Vaira, L. A.
10.1101/2022.02.17.22271116 — Posted: 2022-02-18
Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
Ireland, G., Whitaker, H., Ladhani, S., Baawuah, F., Subbarao, S., Elgohari, S., Smith, A., O'Brien, M., Whillock, C., Martin, O., Moss, P., Ramsay, M. E., Amirthalingam, G., Brown, K. E.
10.1101/2022.02.17.22271126 — Posted: 2022-02-18
Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals
Gehanno, J.-F., Grosjean, J., Darmoni, S. J., Rollin, L.
10.1101/2022.02.16.22271068 — Posted: 2022-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).